Nanobiotix: Monthly update on voting rights and shares

Nanobiotix, a company listed on Euronext Paris and Nasdaq, has released its monthly report on the total number of voting rights and shares comprising its share capital. As of June 30, 2026, the company reports a total of 50,825,682 shares. In terms of voting rights, the theoretical total is 54,486,890 and the exercisable total is 54,464,772.

Nanobiotix is committed to biomedical therapeutic innovation. Headquartered in Paris, it also has a subsidiary in Cambridge, Massachusetts. Nanobiotix's nanotechnology platforms are primarily applied to the fields of oncology and central nervous system disorders.